SEC Tracker
Get the app

Maze Therapeutics MAZE

Maze Therapeutics: reports shareholder vote results

Form
8-K
Filed
Importance
Routine
  • Reports shareholder vote results (5.07)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Maze Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Cullinan Therapeutics CGEM public float $442M, Jun 30, 2025
  2. aTYR PHARMA ATYR public float $464M, Jun 30, 2025
  3. REGENXBIO RGNX public float $385M, Jun 30, 2025
  4. MeiraGTx Holdings MGTX public float $525M, Jun 30, 2025
  5. Iovance Biotherapeutics IOVA public float $535M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.